The Five-Star Quality Rating System isn’t just a mechanism to improve the patient experience; it has also changed the industry from an insurer’s perspective. Here are three ways to buy into the CMS rating system as a means to continuous improvement.
Gispanski
When CMS implemented the Five-Star Quality Rating System, the agency aimed to improve the quality of care and strengthen protection for beneficiaries. Using a scale of one to five stars, these ratings gauge how well a given healthcare plan (payer) covers a patient and meets federal guidelines and recommendations on patient care and services.
Reviews are published online at the Medicare Plan Finder, which not only keeps the system accountable, but also helps patients stay informed while easing the burden of comparing health plans. This system wields significant influence over the Medicare system-but perhaps not as much as it could. According to a 2018 survey by HealthMine, less than one quarter of beneficiaries even know the ratings exist, much less how they impact the quality of their healthcare.
Nevertheless, the star rating system plays a serious role in improving health insurance payers’ performance. Healthcare plans with better ratings tend to attract more members, so there’s a built-in incentive structure to the rating system. Those plans that work to promote and improve their star rating are positioned to capitalize on the opportunity to develop better processes and thus service patients more effectively.
A road map for improved offerings
To provide objective measurements for evaluating health plan quality, CMS uses no fewer than 48 quality measures among five categories, with the most weight sitting in care management - think breast cancer screenings, annual flu vaccines, diabetes care, etc. Additional categories rely more on what a health plan itself can control-areas such as member complaints and changes in plan performance.
One question to ask is: How well are payers performing against this robust set of metrics? To paint a picture of the industry’s star performance, McKinsey analyzed CMS’s data covering 530 Medicare Advantage health plans. It discovered that the overall enrollment-weighted average star score in 2017 (4.00) changed only slightly from 2016 (4.03).
Furthermore, McKinsey’s report confirmed that plans with four or more stars are more likely to see stronger enrollment growth than those below that threshold. Of the 2014 contracts (Medicare/Medicaid contracts that can contain multiple plans) that were still in the market in 2016, those that retained at least a four-star rating experienced nearly 41% growth. Meanwhile, contracts that lost a four-star rating experienced only 8% growth, and contracts that consistently performed below four stars had less than 1% growth.
Related: Four Ways Mobile Remote Patient Monitoring Can Improve Star Ratings
There is a strong correlation here between the rating and enrollment success. If that’s not enough to embrace the Five-Star Quality Rating System as a route to plan improvement, here are three more reasons to support it.
Putting it all together
OK, so you buy into the value of the rating system. What should you do next? Here are three concrete steps that health insurance carriers can take to increase their star ratings:
One of the biggest issues consumers have with health plans is denial of coverage. It’s very important that consumers have access to the information they need and that they receive accurate and fair assessments of their coverage.
The Five-Star Quality Rating System isn’t just a mechanism to improve the patient experience; it has also changed the industry from an insurer’s perspective. When providers buy into the CMS rating system as a means to continuous improvement, they too will benefit.
Austin Gispanski is vice president, business strategy of Exela Technologies, a global business process automation leader providing enterprise software and services to more than 3,700 customers worldwide.
This week on Tuning Into The C-Suite Briana Contreras spoke with Dr. Scott Hayworth, president and CEO of New York-based CareMount Medical. In this interview, the two discussed the importance of patients staying in contact with their doctors for the sake of reducing public health risks and to discuss ongoing care options with them.
Listen
Eric Levin talks PBMs and how Scripta is Tackling the Market's Challenges for Patients
July 22nd 2020MHE's Briana Contreras spoke with CEO of Scripta, Eric Levin. The two discussed the current state of the pharmacy benefit market and how the Scripta organization has been assisting its clients and their prescriptions prior to the COVID-19 pandemic and during.
Listen